In the last 12 months, insiders at Genprex, Inc. ($GNPX) filed 29 transactions with the SEC: 2 open-market purchases totaling $41,523 and 0 sales totaling $0. Net insider sentiment: net buying.
Genprex, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Varner John Rodney (Chairman, President and CEO) — 2 transactions totaling $31,670
- VACZY CATHERINE M (EVP GC Chief Strategy Officer) — 2 transactions totaling $21,478
- Berger Mark Stanley (Chief Medical Officer) — 7 transactions totaling $21,405
- Confer Ryan M. (President, CEO and CFO) — 5 transactions totaling $20,138
- Confer Ryan M. (Chief Financial Officer) — 2 transactions totaling $4,954
View all SEC Filings for Genprex, Inc. (GNPX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 7168 | $2.00 | 21,692.0000 | 2,270,346 | 24.84% | 0.32% |
| Feb. 27, 2026 | Confer Ryan M. | President, CEO and CFO | F | Common Stock | 9330 | $2.00 | 36,331.0000 | 2,270,346 | 20.43% | 0.41% |
| Dec. 22, 2025 | Confer Ryan M. | President, CEO and CFO | A | Common Stock | 45000 | $0.00 | 45,661.0000 | 2,270,346 | 6807.87% | 1.98% |
| Dec. 22, 2025 | Berger Mark Stanley | Chief Medical Officer | A | Common Stock | 28500 | $0.00 | 28,860.0000 | 2,270,346 | 7916.67% | 1.26% |
| Dec. 22, 2025 | Wilson William R Jr. | Director | A | Common Stock | 9000 | $0.00 | 9,157.0000 | 2,270,346 | 5732.48% | 0.40% |
| Dec. 22, 2025 | LONGNECKER BRENT M | Director | A | Common Stock | 9000 | $0.00 | 9,175.0000 | 2,270,346 | 5142.86% | 0.40% |
| Dec. 22, 2025 | Moreno Toscano Jose Antonio | Director | A | Common Stock | 9000 | $0.00 | 9,157.0000 | 2,270,346 | 5732.48% | 0.40% |
| June 30, 2025 | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 4500 | $0.23 | 17,971.0000 | 24,152,848 | 20.03% | 0.02% |
| June 30, 2025 | Confer Ryan M. | President, CEO and CFO | F | Common Stock | 5775 | $0.23 | 32,968.0000 | 24,152,848 | 14.91% | 0.02% |
| Feb. 18, 2025 | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 585 | $0.41 | 22,471.0000 | 0 | 2.54% | 0.00% |
| Feb. 18, 2025 | Confer Ryan M. | President, CEO and CFO | F | Common Stock | 395 | $0.41 | 38,743.0000 | 0 | 1.01% | 0.00% |
| Dec. 5, 2024 | Berger Mark Stanley | Chief Medical Officer | A | Common Stock | 18250 | $0.00 | 23,056.0000 | 0 | 379.73% | 0.00% |
| Dec. 5, 2024 | LONGNECKER BRENT M | Director | A | Common Stock | 4750 | $0.00 | 8,720.0000 | 0 | 119.65% | 0.00% |
| Dec. 5, 2024 | Wilson William R Jr. | Director | A | Common Stock | 4750 | $0.00 | 7,845.0000 | 0 | 153.47% | 0.00% |
| Dec. 5, 2024 | Moreno Toscano Jose Antonio | Director | A | Common Stock | 4750 | $0.00 | 7,845.0000 | 0 | 153.47% | 0.00% |
| Dec. 5, 2024 | Confer Ryan M. | President, CEO and CFO | A | Common Stock | 29375 | $0.00 | 39,138.0000 | 0 | 300.88% | 0.00% |
| Feb. 18, 2024 | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 1319 | $4.40 | 4,806.0000 | 0 | 21.53% | 0.00% |
| Feb. 18, 2024 | Varner John Rodney | Chairman, President and CEO | F | Common Stock | 2642 | $4.40 | 26,872.0000 | 0 | 8.95% | 0.00% |
| Feb. 18, 2024 | Confer Ryan M. | Chief Financial Officer | F | Common Stock | 1126 | $4.40 | 9,763.0000 | 0 | 10.34% | 0.00% |
| June 27, 2023 | Wilson William R Jr. | Director | A | Common Stock | 123795 | $0.00 | 123,795.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | Moreno Toscano Jose Antonio | Director | A | Common Stock | 123795 | $0.00 | 123,795.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | LONGNECKER BRENT M | Director | A | Common Stock | 123795 | $0.00 | 158,795.0000 | 0 | 353.70% | 0.00% |
| April 21, 2023 | VACZY CATHERINE M | EVP GC Chief Strategy Officer | P | Common Stock | 20000 | $1.07 | 265,000.0000 | 0 | 8.16% | 0.00% |
| April 21, 2023 | Varner John Rodney | Chairman, President and CEO | P | Common Stock | 19000 | $1.06 | 1,180,535.0000 | 0 | 1.64% | 0.00% |
| Feb. 18, 2023 | Kumar Hermant | Chief Mfgr & Tech Officer | A | Common Stock | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2023 | Confer Ryan M. | Chief Financial Officer | A | Common Stock | 245000 | $0.00 | 435,499.0000 | 0 | 128.61% | 0.00% |
| Feb. 18, 2023 | Berger Mark Stanley | Chief Medical Officer | A | Common Stock | 245000 | $0.00 | 245,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 18, 2023 | Varner John Rodney | President & CEO | A | Common Stock | 625000 | $0.00 | 1,161,535.0000 | 0 | 116.49% | 0.00% |
| Feb. 18, 2023 | VACZY CATHERINE M | EVP GC Chief Strategy Officer | A | Common Stock | 245000 | $0.00 | 245,000.0000 | 0 | 9999.99% | 0.00% |